Akrolyth Advisory provides expert commercial strategy and business planning, opportunity evaluation and acquisition/licensing support, valuation, modeling and forecasting, analytical, and market research services with a focus on Life Sciences – for pharma, biotech, medtech, startups, and investors.
We specialize in providing customized solutions to non-traditional business challenges, combining expert analytical acumen with in-depth and wide-ranging market experience.
Akrolyth has a broad range of experience across numerous therapeutic areas, with particular expertise in rare/orphan diseases, specialty and emerging therapies, diagnostics, and medical devices. We have worked extensively on the US and EU markets, as well as Latin America and Asia.